Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | SM88 |
| Synonyms | |
| Therapy Description |
SM88 is a modified tyrosine derivative that may interfere with protein synthesis, leading to oxidative damage and cell death in tumor cells (PMID: 31358523, PMID: 30929156). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| SM88 | SM-88|Racemetyrosine|Racemetirosine | SM88 is a modified tyrosine derivative that may interfere with protein synthesis, leading to oxidative damage and cell death in tumor cells (PMID: 31358523, PMID: 30929156). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT02796898 | Phase Ib/II | SM88 | Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer | Completed | USA | 0 |